Pharmafile Logo
Pharmafocus logo
Advanced Search

Phase 2 study explores imaging approach for interstitial lung disease

June 5, 2026
Research and Development interstitial lung disease

Serac Healthcare has presented phase 2 data suggesting its investigational imaging agent, 99mTc-maraciclatide, may help distinguish active inflammation from fibrosis …

News

Laverock secures funding for gene-control platform development

June 4, 2026
Research and Development Laverock Therapeutics

Laverock Therapeutics has been awarded more than £2.2m in grant funding to support development of its gene-control platform and expand …

News

LifeArc and Elpida partner to advance gene therapies for ultra-rare childhood diseases

June 3, 2026
Research and Development gene therapies

LifeArc has announced a partnership with Elpida Therapeutics to support development of gene therapies for three ultra-rare neurodegenerative diseases affecting …

News

Well Pharmacy and Alzheimer’s Society launch dementia partnership

June 2, 2026
Research and Development dementia

Well Pharmacy has announced a partnership with Alzheimer’s Society aimed at improving support for people living with dementia and their …

News

China approves fruquintinib combination for kidney cancer

May 29, 2026
Kidney cancer, Nephrology

China’s National Medical Products Administration (NMPA) has approved a combination of ELUNATE (fruquintinib) and TYVYT (sintilimab) for patients with advanced …

News

BIOTRONIK, Charité and GHCF launch digital cardiology partnership

May 28, 2026
Biotronik, Cardiology

BIOTRONIK, Charité – Universitätsmedizin Berlin and the German Heart Center Foundation (GHCF) have announced a partnership focused on advancing digital …

News

Endometriosis study begins recruitment in UK hospitals

May 28, 2026
Clinical Research, Recruitment Cyclana Bio, endometriosis

Cyclana Bio has recruited the first patients into a 500-participant observational study investigating the biological mechanisms behind endometriosis, following approval …

News
drug-trials

MHRA authorises donidalorsen for hereditary angioedema prevention

May 27, 2026
Research and Development donidalorsen

Otsuka Pharmaceuticals UK announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has authorised Dawnzera (donidalorsen) for routine prevention …

News

Partnership aims to expand early access to medicines

May 26, 2026
Maprium, The Medicine Access Channel

Maprium and The Medicine Access Channel have announced a partnership intended to support earlier patient access to medicines that have …

News

SMC accepts amivantamab and lazertinib for EGFR-positive lung cancer

May 22, 2026
SMC, amivantamab, lazertinib, lung cancer

The Scottish Medicines Consortium (SMC) has accepted Rybrevant (amivantamab) in combination with Lazcluze (lazertinib) for use within NHS Scotland as …

News

BioDuro and CTI Biotechnology in preclinical drug development partnership

May 21, 2026
Research and Development BioDuro, CTI Biotechnology

BioDuro has announced a strategic partnership with CTI Biotechnology. The collaboration will leverage the complementary strengths of both companies across critical stages …

News

Sygnature Discovery appoints Susanne Back as Head of In Vivo Pharmacology

May 21, 2026
Sygnature Discovery, Vivo Pharmacology

Sygnature Discovery, an integrated drug discovery contract research organisation (CRO), has announced the appointment of Susanne Back as Head of …

Appointment

NICE recommends sotatercept for pulmonary arterial hypertension

May 20, 2026
NICE, Winrevair, pulmonary arterial hypertension, sotatercept

The National Institute for Health and Care Excellence (NICE) has recommended Winrevair (sotatercept) as a treatment option for adults with …

News

Vetter begins construction of new injectable medicines facility

May 20, 2026
Manufacturing and Production Vetter

Vetter, a contract development and manufacturing organisation (CDMO), has begun construction of a new pharmaceutical manufacturing site in Saarlouis, Germany, …

News

Study explores genomic testing approach for unexplained infertility

May 14, 2026
Research and Development infertility

Researchers across the Asia Pacific region have reported findings from a study investigating whether long-read whole genome sequencing could improve …

News

Celtic Renewables receives £7m to develop bio-based solvents

May 14, 2026
Manufacturing and Production Celtic Renewables

Scottish green chemicals company Celtic Renewables is part of a consortium that has secured £7m in funding to support development …

News

Synnovis and SOPHiA GENETICS expand liquid biopsy testing in NHS cancer care

May 13, 2026
Research and Development Sophia Genetics, Synnovis

Synnovis and SOPHiA GENETICS have announced a collaboration to expand blood-based cancer testing for patients with lung and breast cancer …

News

MHRA to establish Northern Ireland hub for life sciences sector

May 13, 2026
MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is establishing a new hub in Northern Ireland aimed at strengthening engagement …

News

Shilpa Medicare signs manufacturing deal with NXI Therapeutics

May 12, 2026
Manufacturing and Production Shilpa Medicare

Shilpa Medicare has entered into a long-term development and manufacturing agreement with Swiss biotech company NXI Therapeutics focused on an …

News

CGT Catapult backs AI platform for gene therapy delivery

May 12, 2026
Cell and Gene Therapy Catapult

Cell and Gene Therapy Catapult (CGT Catapult) is providing investment to UK biotech company Lir Therapeutics to support development of …

News
The Gateway to Local Adoption Series

Latest content

Closing the immunisation gap: partnership working that delivered at scale

June 5, 2026

Phase 2 study explores imaging approach for interstitial lung disease

June 5, 2026

Laverock secures funding for gene-control platform development

June 4, 2026

LifeArc and Elpida partner to advance gene therapies for ultra-rare childhood diseases

June 3, 2026

Well Pharmacy and Alzheimer’s Society launch dementia partnership

June 2, 2026